All In Biotech

Drug Trial Radar · NCT07720375

A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis Bronchiectasis

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis Bronchiectasis (ATMOS)

Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Aug 5, 2026

Primary completion

Feb 28, 2029

Study completion Apr 26, 2029

Sponsor

Lead sponsor
UCB Biopharma SRLUCB
Sponsor type
Industry
First posted
Jul 22, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to investigate the efficacy of galvokimig versus placebo on the time to the first pulmonary exacerbation in study participants with non-cystic fibrosis bronchiectasis (NCFB)

Conditions

  • Non-cystic Fibrosis Bronchiectasis

Interventions

  • GalvokimigBiological

    Drug: Galvokimig Pharmaceutical form: Solution for injection

  • PlaceboBiological

    Drug: Placebo Pharmaceutical form: Solution for injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time from intervention assignment to first moderate or severe pulmonary exacerbationTime frame: Up to Week 52

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Ncfb01 50012

    Newport Beach, California · Recruiting

  • Ncfb01 50003

    Brandon, Florida · Recruiting

  • Ncfb01 50005

    Plantation, Florida · Recruiting

  • Ncfb01 50004

    DuBois, Pennsylvania · Recruiting

  • Ncfb01 50007

    Rock Hill, South Carolina · Recruiting

  • Ncfb01 50001

    McKinney, Texas · Recruiting

  • Ncfb01 50010

    Mesquite, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.